Ultragenyx Pharmaceutical

Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.

Industries

Stage

Post IPO Equity

Employees

501-1,000

Links

Org chart

Emil D. Kakkis
CEO & President
Collapse
Dennis Huang
Chief Technical Operations Officer & EVP, Gene Therapy Research & Development
Erik Harris
EVP, Chief Commercial Officer
Ernie Meyer
EVP, Chief Human Resources Officer
John Pinion
EVP, Translational Sciences & Chief Quality Operations Officer
Eric Crombez
Chief Medical Officer & EVP
Thomas Kassberg
EVP, Chief Business Officer
Karah Parschauer
EVP, Chief Legal Officer
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.